Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 21,535 clinical trials worldwide
Search
Showing 15351-15400 of 21,535 trials
Active filters:
Status: Active, not recruiting
Clinical Trials (21,535)
NCT05267496
Oscillating Positive Expiratory Pressure Therapy for Patients With Thoracic Neoplasms Undergoing Chest Surgery
NA
Active, not recruiting
72 participants
Started: Aug 13, 2019 · Completed: Dec 31, 2025
3 conditions
1 sponsor
1 location
NCT04047706
Nivolumab, BMS-986205, and Radiation Therapy With or Without Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma
PHASE1
Active, not recruiting
18 participants
Started: Aug 13, 2019 · Completed: Jun 1, 2027
1 condition
2 sponsors
1 location
NCT04009499
A Study to Assess the Long-term Safety, Tolerability, and Efficacy of Bimekizumab in the Treatment of Subjects With Active Psoriatic Arthritis
PHASE3
Active, not recruiting
1,131 participants
Started: Aug 13, 2019 · Completed: May 25, 2026
1 condition
1 sponsor
138 locations
NCT04071457
S1803, Lenalidomide +/- Daratumumab/rHuPh20 as Post-ASCT Maintenance for MM w/MRD to Direct Therapy Duration
PHASE3
Active, not recruiting
1,100 participants
Started: Aug 13, 2019 · Completed: Jul 1, 2040
1 condition
3 sponsors
842 locations
NCT04734158
CORNEAL EPITHELIAL MAPPING IN DIABETICS
N/A
Active, not recruiting
153 participants
Started: Aug 12, 2019 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT04036435
Long-Term Study That Measures the Safety and Efficacy of Deucravacitinib (BMS-986165) in Participants With Psoriasis
PHASE3
Active, not recruiting
1,466 participants
Started: Aug 12, 2019 · Completed: Jul 26, 2026
1 condition
1 sponsor
302 locations
NCT04035811
Prospective Clinical Assessment Study in Children With Achondroplasia (ACH)
N/A
Active, not recruiting
271 participants
Started: Aug 12, 2019 · Completed: Jun 30, 2026
1 condition
1 sponsor
32 locations
NCT04035005
A Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis
PHASE3
Active, not recruiting
1,013 participants
Started: Aug 12, 2019 · Completed: Jan 19, 2028
1 condition
1 sponsor
159 locations
NCT03975634
Transcutaneous Spinal Stimulation: Safety and Feasibility for Trunk Control in Children With Spinal Cord Injury
NA
Active, not recruiting
9 participants
Started: Aug 12, 2019 · Completed: Jun 30, 2025
1 condition
2 sponsors
1 location
NCT05773222
Efficacy and Safety of Apixaban in Korean Frail Atrial Fibrillation Patient
N/A
Active, not recruiting
2,500 participants
Started: Aug 12, 2019 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT03735420
Xanthohumol Metabolism and Signature
PHASE1
Active, not recruiting
30 participants
Started: Aug 12, 2019 · Completed: Dec 31, 2024
1 condition
3 sponsors
1 location
NCT04196452
A Retrospective Observational Study on the Long-term Effects of Ipilimumab-treated Pediatric Participants in the Dutch Melanoma Treatment Registry (DMTR)
N/A
Active, not recruiting
10 participants
Started: Aug 12, 2019 · Completed: Jun 30, 2034
1 condition
1 sponsor
0 locations
NCT03706482
Boost Brittle Bones Before Birth
PHASE1/PHASE2
Active, not recruiting
18 participants
Started: Aug 12, 2019 · Completed: Apr 30, 2030
1 condition
8 sponsors
1 location
NCT03742193
Pulmonary Resectable Metastases of Osteosarcoma With Anti-angiogenics and CHemotherapy
PHASE2
Active, not recruiting
43 participants
Started: Aug 11, 2019 · Completed: Dec 30, 2023
3 conditions
1 sponsor
1 location
NCT04037358
RAdium-223 and SABR Versus SABR for Oligometastatic Prostate Cancers
PHASE2
Active, not recruiting
64 participants
Started: Aug 9, 2019 · Completed: Dec 31, 2028
1 condition
3 sponsors
1 location
NCT04352816
Magnetocardiography (MCG) Parameters in the Prediction of Future ICD Therapy
NA
Active, not recruiting
103 participants
Started: Aug 9, 2019 · Completed: Dec 31, 2026
2 conditions
1 sponsor
1 location
NCT04083963
Phase 2 Trial of Neoadjuvant Weekly Carboplatin Plus Paclitaxel in Triple Negative Breast Cancer
PHASE2
Active, not recruiting
13 participants
Started: Aug 9, 2019 · Completed: Sep 27, 2026
1 condition
1 sponsor
1 location
NCT04001829
Taxane and Taxane-Induced Peripheral Neuropathy in African American Patients With Stage I-III Breast Cancer
PHASE2
Active, not recruiting
249 participants
Started: Aug 9, 2019 · Completed: Mar 31, 2027
21 conditions
2 sponsors
485 locations
NCT03584152
Postoperative Pain Management in Rhinoplasty
PHASE2
Active, not recruiting
130 participants
Started: Aug 9, 2019 · Completed: Sep 30, 2025
1 condition
1 sponsor
1 location
NCT04578678
Can Subthalamic Stimulation Using Directional Electrodes Improve Postoperative Management in Parkinson's Disease
N/A
Active, not recruiting
105 participants
Started: Aug 9, 2019 · Completed: Mar 31, 2026
2 conditions
2 sponsors
4 locations
NCT06400251
Testing Ipatasertib as Potentially Targeted Treatment in Cancers With AKT Genetic Changes (MATCH - Subprotocol Z1K)
PHASE2
Active, not recruiting
35 participants
Started: Aug 8, 2019 · Completed: Dec 31, 2025
5 conditions
1 sponsor
1 location
NCT04106856
Losartan and Hypofractionated Rx After Chemo for Tx of Borderline Resectable or Locally Advanced Unresectable Pancreatic Cancer (SHAPER)
PHASE1
Active, not recruiting
22 participants
Started: Aug 8, 2019 · Completed: Aug 8, 2026
7 conditions
2 sponsors
1 location
NCT03873259
Intraoperative Assessment of of Burst Wave Lithotripsy (BWL)
NA
Active, not recruiting
40 participants
Started: Aug 8, 2019 · Completed: Apr 30, 2026
2 conditions
3 sponsors
2 locations
NCT04040634
Optimal Blood Pressure for the prevenTIon of Major vAscuLar Events in Patients With DIABETES Mellitus (OPTIMAL-DIABETES)
NA
Active, not recruiting
9,479 participants
Started: Aug 8, 2019 · Completed: Dec 31, 2025
4 conditions
2 sponsors
32 locations
NCT03869905
Aquamin® as an Adjuvant Intervention for Ulcerative Colitis
PHASE2
Active, not recruiting
40 participants
Started: Aug 8, 2019 · Completed: Dec 31, 2027
1 condition
1 sponsor
1 location
NCT03622788
Cytokine-Treated Veto Cells in Treating Patients With Hematologic Malignancies Following Stem Cell Transplant
PHASE1/PHASE2
Active, not recruiting
16 participants
Started: Aug 8, 2019 · Completed: Dec 1, 2025
13 conditions
1 sponsor
1 location
NCT03779334
A Study of Risdiplam in Infants With Genetically Diagnosed and Presymptomatic Spinal Muscular Atrophy
PHASE2
Active, not recruiting
26 participants
Started: Aug 7, 2019 · Completed: Mar 31, 2027
1 condition
1 sponsor
7 locations
NCT03375762
REMOTE Ischemic Perconditioning Among Acute Ischemic Stroke Patients ( REMOTE-CAT)
NA
Active, not recruiting
572 participants
Started: Aug 7, 2019 · Completed: Apr 1, 2024
1 condition
2 sponsors
1 location
NCT04430725
Microwave Ablation or Wedge Resection for the Treatment of Lung, Sarcoma and Colorectal Lesions, ALLUME Study
N/A
Active, not recruiting
74 participants
Started: Aug 7, 2019 · Completed: Jan 1, 2026
22 conditions
2 sponsors
1 location
NCT04030455
Cisplatin, Docetaxel, and Pembrolizumab in Treating Patients With Stage II-III Laryngeal Cancer
PHASE2
Active, not recruiting
27 participants
Started: Aug 7, 2019 · Completed: Nov 1, 2025
3 conditions
2 sponsors
1 location
NCT04058652
Use of Transcutaneous Electrical Nerve Stimulation for Reducing Biologic Injection Site Pain(TENS Study)
NA
Active, not recruiting
20 participants
Started: Aug 7, 2019 · Completed: Jul 31, 2026
1 condition
1 sponsor
1 location
NCT03893487
Fimepinostat in Treating Brain Tumors in Children and Young Adults
EARLY_PHASE1
Active, not recruiting
30 participants
Started: Aug 7, 2019 · Completed: Aug 31, 2027
5 conditions
4 sponsors
19 locations
NCT03884712
Using CalmiGo to Manage Anxiety and Panic Attack Symptoms in the Emergency Department
NA
Active, not recruiting
35 participants
Started: Aug 7, 2019 · Completed: Oct 1, 2025
2 conditions
2 sponsors
1 location
NCT04304066
Research for the Molecular Imaging of the PD-L1 Targeting Tracer
NA
Active, not recruiting
50 participants
Started: Aug 6, 2019 · Completed: Dec 31, 2024
2 conditions
1 sponsor
1 location
NCT04022343
Neoadjuvant Cabozantinib in Treating Patients With Locally Advanced Kidney Cancer
PHASE2
Active, not recruiting
22 participants
Started: Aug 6, 2019 · Completed: Dec 9, 2025
3 conditions
4 sponsors
1 location
NCT04036409
Optimal Blood Pressure for the prevenTIon of Major vAscuLar Events in Stroke Patients
NA
Active, not recruiting
4,369 participants
Started: Aug 5, 2019 · Completed: Dec 31, 2025
4 conditions
2 sponsors
30 locations
NCT04072952
A Phase 1/2 Trial of ARV-471 Alone and in Combination With Palbociclib (IBRANCE®) in Patients With ER+/HER2- Locally Advanced or Metastatic Breast Cancer
PHASE1/PHASE2
Active, not recruiting
217 participants
Started: Aug 5, 2019 · Completed: Nov 30, 2025
1 condition
2 sponsors
16 locations
NCT04261543
The Effect of High Protein and Early Resistance Exercise Versus Usual Care in Critically Ill Patients
NA
Active, not recruiting
120 participants
Started: Aug 5, 2019 · Completed: Dec 1, 2025
1 condition
1 sponsor
1 location
NCT04008030
A Study of Nivolumab, Nivolumab Plus Ipilimumab, or Investigator's Choice Chemotherapy for the Treatment of Participants With Deficient Mismatch Repair (dMMR)/Microsatellite Instability High (MSI-H) Metastatic Colorectal Cancer (mCRC)
PHASE3
Active, not recruiting
839 participants
Started: Aug 5, 2019 · Completed: Jun 10, 2026
1 condition
2 sponsors
157 locations
NCT03770429
AZD6738 for Patients With Progressive MDS or CMML
PHASE1
Active, not recruiting
52 participants
Started: Aug 5, 2019 · Completed: May 31, 2026
2 conditions
2 sponsors
4 locations
NCT04045379
LASER and Radiofrequency and Genitourinary Syndrome of Menopause
NA
Active, not recruiting
195 participants
Started: Aug 5, 2019 · Completed: Aug 31, 2025
3 conditions
2 sponsors
1 location
NCT04051502
ICG-Enabled Mapping of Ovarian Sentinel Lymph Nodes: A Feasibility Study
EARLY_PHASE1
Active, not recruiting
48 participants
Started: Aug 5, 2019 · Completed: Aug 31, 2026
2 conditions
1 sponsor
7 locations
NCT06183320
Can Flowable Bulk Fill Composites be Used in Proximal Area of Class II Restorations
NA
Active, not recruiting
38 participants
Started: Aug 5, 2019 · Completed: Dec 30, 2026
1 condition
1 sponsor
1 location
NCT04012996
2-level Cervical Disc Replacement Comparing Prodisc C SK & Vivo to Mobi-C
NA
Active, not recruiting
390 participants
Started: Aug 5, 2019 · Completed: May 13, 2028
1 condition
1 sponsor
30 locations
NCT03977129
Quantitative Flow Ratio (QFR) Guided Coronary Artery Bypass Grafting for Patients Undergoing Primary Valve Surgery With Concomitant Coronary Artery Disease
NA
Active, not recruiting
792 participants
Started: Aug 4, 2019 · Completed: Aug 31, 2027
2 conditions
2 sponsors
12 locations
NCT03512405
Pembrolizumab and Blinatumomab in Treating Participants With Recurrent or Refractory Acute Lymphoblastic Leukemia
PHASE1/PHASE2
Active, not recruiting
36 participants
Started: Aug 2, 2019 · Completed: Nov 11, 2025
4 conditions
2 sponsors
1 location
NCT04304248
Neoadjuvant Toripalimab Plus Platinum-based Doublet for Stage III Non-small Cell Lung Cancer
PHASE2
Active, not recruiting
30 participants
Started: Aug 1, 2019 · Completed: Jul 30, 2026
1 condition
1 sponsor
1 location
NCT04011189
Pain Detection Through Automated Video Analysis
NA
Active, not recruiting
370 participants
Started: Aug 1, 2019 · Completed: Dec 31, 2026
1 condition
1 sponsor
2 locations
NCT05515640
Dysautonomia and Systemic Interactions in Traumatic Brain Injury
N/A
Active, not recruiting
24 participants
Started: Aug 1, 2019 · Completed: Jun 30, 2024
4 conditions
4 sponsors
1 location
NCT04198545
Ethnic Differences in Iron Absorption (FeGenes)
N/A
Active, not recruiting
515 participants
Started: Aug 1, 2019 · Completed: Dec 31, 2025
2 conditions
3 sponsors
2 locations
Previous
1
More pages
305
306
307
308
309
310
311
More pages
431
Next